TGTX peer analysis
TG Therapeutics (TGTX) against its competitors: price, today's move, 1-year return and market value side by side.
TGTX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ADAG Adagene | $2.51 | -6.34% | 30.73% | – |
| ADCT ADC Therapeutics | $1.53 | 2.68% | -66.95% | $195.33M |
| CLDX Celldex Therapeutics | $29.16 | -3.12% | 12.15% | $2.36B |
| CRVS Corvus Pharmaceuticals | $10.03 | -1.96% | 29.25% | $843.73M |
| GMAB Genmab | $55.57 | -2.61% | 93.83% | $35.09B |
| IPHA Innate Pharma | $1.46 | -1.35% | -33.64% | $163.08M |
| MGNX MacroGenics | $2.40 | 0.84% | 50.47% | $152.88M |
| XNCR Xencor | $29.59 | -0.77% | 109.41% | $2.22B |
| TGTX TG Therapeutics | $60.50 | -1.11% | 77.84% | $9.36B |
- TGTX's peers: ADAG (Adagene), ADCT (ADC Therapeutics), CLDX (Celldex Therapeutics), CRVS (Corvus Pharmaceuticals), GMAB (Genmab), IPHA (Innate Pharma), MGNX (MacroGenics), XNCR (Xencor).
Updated 2026-11-02 18:32 UTC